- Lupin, Aurobindo get USFDA nod for HIV drug
Drug firms Lupin Ltd and Aurobindo Pharma today said they have received approval to sell generic Combivir tablets, used in treating HIV inf...
16 May, 2012, 01.59 PM IST
- Hedged all forex exposure for short term: S Ramesh, CFO, Lupin
In an interview with ET Now, S Ramesh, CFO, Lupin, talks about pharma and company's strategies.
27 Dec, 2011, 02.18 PM IST
- Glaxo takes new AIDS drug into final-stage tests
GlaxoSmithKline and its partner Shionogi are progressing a new drug against HIV into final-stage clinical testing, ramping up competition i...
21 Jul, 2010, 02.37 PM IST
- It’s patent vs patient in AIDS fight
The battle lines between Western pharmaceutical transnationals and NGOs and patients’ associations are now drawn sharper than ever before. ...
15 Feb, 2007, 01.50 AM IST
- GSK withdraws patent application for AIDS drug
Global pharmaceutical major GlaxoSmithKline (GSK) has withdrawn its patent application in India for anti-AIDS drug Combivir, which has been...
21 Aug, 2006, 02.40 PM IST
- Of patents and pre-grant oppositions
On January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...
23 Jun, 2006, 12.09 AM IST